What is Becton, Dickinson and Company's biopharma systems — goodwill, foreign currency translation, gain (loss)?

Becton, Dickinson and Company (BDX) reported biopharma systems — goodwill, foreign currency translation, gain (loss) of $0.00 in Q1 2026.

Discontinued — last reported Q3 '20

Business Segments · Goodwill, Foreign Currency Translation, Gain (Loss)

BioPharma Systems — Goodwill, Foreign Currency Translation, Gain (Loss)

Analysis

StatementSegment

CategoryRisk

SignalContext dependent

VolatilityVolatile

First reportedQ1 2019

Last reportedQ3 2020

How to read this metric

Fluctuations here are driven by macroeconomic currency trends rather than operational performance, though they impact the overall balance sheet valuation.

Detailed definition

This metric tracks the impact of fluctuations in foreign exchange rates on the carrying value of goodwill denominated in...

Peer comparison

Similar to foreign currency translation adjustments reported by multinational corporations with significant international assets.

Metric ID: bdx_segment_biopharma_systems_goodwill_foreign_currency_translation_gain_loss

Historical Data

2 periods

	Q4 '25	Q1 '26
Value	$0.00	$0.00

Range$0.00 – $0.00

Similar Metrics at Other Companies

Cardinal HealthCAH View metric

DanaherDHR View metric

McKessonMCK View metric

CVS HealthCVS View metric

International Business MachinesIBM View metric

Frequently Asked Questions

What is Becton, Dickinson and Company's biopharma systems — goodwill, foreign currency translation, gain (loss)?: Becton, Dickinson and Company (BDX) reported biopharma systems — goodwill, foreign currency translation, gain (loss) of $0.00 in Q1 2026.
What does biopharma systems — goodwill, foreign currency translation, gain (loss) mean?: The change in the reported value of goodwill for the BioPharma Systems segment caused solely by shifts in foreign currency exchange rates.